Canada · Health Canada Drug Product Database
TRIPACEL HYBRID
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43396
- DIN
- 02224143
- Form
- Suspension
- Company as listed by source
- SANOFI VACCINES CANADA LTD.
- Source status
- Cancelled Post Market (2014-09-19)
- Source last updated
- 2026-06-25
Source-listed ingredients
- PERTUSSIS TOXOID — 20 MCG — per 0.5 ML
- FILAMENTOUS HAEMAGGLUTININ — 20 MCG — per 0.5 ML
- FIMBRIAE — 5 MCG — per 0.5 ML
- PERTACTIN — 3 MCG — per 0.5 ML
- DIPHTHERIA TOXOID — 15 LF — per 0.5 ML
- TETANUS TOXOID — 5 LF — per 0.5 ML
These values do not establish equivalence or a dose recommendation.
Packages
- 5 X 0.5ml (1 Dose) Ampoules
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →